Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Biotech Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche sales force Sanofi-Aventis Schering Plough Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Category Archives: Corporate Responsibility
HBA Names Woman of the Year
GSK’s Deirdre Connelly has been named the Healthcare Businesswomen’s Association’s Woman of the Year for 2010. Connelly, who just passed the one-year mark as president of GSK’s North American pharmaceuticals unit, is the 21st woman to win the organization’s “WOTY” award, which comes on the heels of another honor: She was ranked #37 in Fortune’s [...]
Also posted in News, People, leadership Tagged Deirdre Connelly, Eli Lilly, GSK, HBA, WOTY Leave a comment
Pharma and Haiti: Can Altruism Backfire?
Guest blog by Pharm Exec Europe’s Jacky Law.
Pharma companies are responding swiftly to the recent earthquake in Haiti with millions of dollars in cash and drugs. GlaxoSmithKline boasted, for example, that its initial $1.2 million offering of medicines — mainly oral and topical antibiotics — was on the first airlift to the Caribbean island and [...]
Also posted in Global, Guest Blog, News Tagged Big Pharma, corporate social responsibility, donations, Haiti, Johnson & Johnson, Pharma Leave a comment
Witty Proposes Price Cap for Poor Nations
GlaxoSmithKline CEO Andrew Witty proposed Friday to slash drug prices in the world’s 50 poorest countries and reinvest 20 percent of the profits in bolstering local health care. In a speech at Harvard Medical School Friday, Witty said drug prices will be capped at 25 percent of what they cost in developed nations. He also [...]
Clinton Tinkers With Malaria Market
A team of reporters and camera crews packed into the headquarters of the Clinton Foundation on West 125th Street this afternoon to hear the details of former President Bill Clinton’s plan to tinker with the market for malaria drugs “in a way that has positive implications for the pharmaceutical companies,” he said.
Posted in Corporate Responsibility Tagged ACT, Africa, AIDS, artemisinin, Bill Clinton, Clinton Foundation, HIV, R&D 4 Comments

Takeda Changes Dexlansoprazole Brand Name From Kapidex to Dexilant